Cash Flow Statement
Quarterly Data
The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31).
The financial trajectory of the company over the analyzed period reflects a transition from a capital-intensive growth phase to a stage of operational optimization and cash flow maximization. Operating cash flows have demonstrated consistent strength and an overall upward trend, providing a stable foundation for dividend payments and debt management.
- Operating Cash Flow and Earnings Performance
- Net income remained relatively stable between 2018 and 2019, averaging approximately 300 million USD per quarter. A significant contraction occurred in the first quarter of 2020, resulting in a loss of 142 million USD, which coincided with a substantial impairment charge of 642 million USD. Following this period, earnings recovered and entered a growth phase, peaking at 1,049 million USD in the first quarter of 2023. This spike was heavily influenced by a non-recurring Medford settlement gain of 779 million USD. Cash provided by operating activities has generally grown from roughly 500 million USD per quarter in early 2018 to peak at 1,221 million USD in March 2023, indicating strong core cash-generating capabilities.
- Capital Expenditure and Investing Trends
- A distinct shift in investment strategy is observable. From March 2018 through March 2020, the company maintained an aggressive capital expenditure program, with quarterly spending frequently exceeding 800 million USD and peaking at 1,109 million USD in December 2019. Starting in 2021, capital expenditures decreased significantly, stabilizing in a range between 147 million USD and 327 million USD per quarter. This reduction suggests a pivot from major infrastructure expansion to maintenance and targeted investments. Cash used in investing activities mirrored this trend, moving from heavy outflows to more modest levels, with a brief positive inflection in the first quarter of 2023 due to settlement proceeds.
- Financing Activities and Capital Allocation
- Financing activities were primarily utilized to fund the heavy capital expenditure cycle of 2018 through 2020. During this window, there were frequent and large issuances of long-term debt, such as the 1,993 million USD issuance in September 2019. In contrast, the period from 2021 to 2023 is characterized by a focus on debt reduction and shareholder returns. Repayments of long-term debt became more frequent, including a significant 896 million USD repayment in September 2022. Dividend payments have been increased incrementally and consistently, rising from 316 million USD per quarter in early 2018 to 428 million USD by June 2023, reflecting a commitment to returning capital to shareholders.
- Working Capital and Non-Recurring Impacts
- Changes in assets and liabilities have exhibited significant quarterly volatility, particularly in accounts receivable and accounts payable, which are characteristic of the industry's operational cycle. Non-recurring items played a pivotal role in specific quarters, most notably the 642 million USD impairment in early 2020 and the Medford settlement in early 2023, which provided both a gain on the income statement and a cash infusion of 328 million USD in investing activities. These events created temporary deviations from the underlying operational cash flow trends.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?